Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Mach7 Technologies ( (AU:M7T) ) has provided an update.
Mach7 Technologies has announced the appointment of Ms. Naomi Lawrie as the new Company Secretary, effective June 24, 2025, following team reassignments at Vistra (Australia) Pty Ltd. Ms. Lawrie, a corporate lawyer with over 20 years of experience in health and technology sectors, will be responsible for communication with the ASX regarding listing rule matters. This change is expected to strengthen Mach7’s corporate governance and compliance framework, potentially enhancing its operational efficiency and industry positioning.
The most recent analyst rating on (AU:M7T) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies is a medical imaging technology provider that develops innovative data management and image viewing solutions for healthcare organizations. Its core offering, the Mach7 Enterprise Imaging Solution (EIS), includes a Vendor Neutral Archive, eUnity Enterprise Diagnostic Viewer, and Diagnostic Workflow Applications. The company serves a global network of customers, including expansive Integrated Delivery Networks, National Health Systems, small independent provider groups, and private radiology practices.
Average Trading Volume: 260,789
Technical Sentiment Signal: Sell
Current Market Cap: A$83.23M
Learn more about M7T stock on TipRanks’ Stock Analysis page.